邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

多发内分泌肿瘤治疗共识与争议

童安莉,  李汉忠

downloadPDF
文章导航 > 协和医学杂志  > 2020 >  11(4): 365-369
童安莉, 李汉忠. 多发内分泌肿瘤治疗共识与争议[J]. 协和医学杂志, 2020, 11(4): 365-369. doi: 10.3969/j.issn.1674-9081.2020.04.002
引用本文: 童安莉, 李汉忠. 多发内分泌肿瘤治疗共识与争议[J]. 协和医学杂志, 2020, 11(4): 365-369. doi: 10.3969/j.issn.1674-9081.2020.04.002
shu
An-li TONG, Han-zhong LI. Consensus and Controversy on the Treatment of Multiple Endocrine Neoplasia[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 365-369. doi: 10.3969/j.issn.1674-9081.2020.04.002
Citation: An-li TONG, Han-zhong LI. Consensus and Controversy on the Treatment of Multiple Endocrine Neoplasia[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 365-369. doi: 10.3969/j.issn.1674-9081.2020.04.002
shu

多发内分泌肿瘤治疗共识与争议

doi: 10.3969/j.issn.1674-9081.2020.04.002
  • 1.

    中国医学科学院 北京协和医学院 北京协和医院 内分泌科 国家卫健委内分泌重点实验室, 北京 100730

  • 2.

    中国医学科学院 北京协和医学院 北京协和医院 泌尿外科

基金项目: 

中国医学科学院医学与健康科技创新工程 2017-12M-1-001

详细信息
    通讯作者:

    李汉忠  电话:010-69152510, E-mail:hzlipumch@163.com

  • 中图分类号: R58

Consensus and Controversy on the Treatment of Multiple Endocrine Neoplasia

  • 1.

    Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

More Information
    Corresponding author: LI Han-zhong  Tel: 86-10-69152510, E-mail:hzlipumch@163.com

    摘要
  • 摘要: 多发内分泌肿瘤(multiple endocrine neoplasia, MEN)是一种累及多种内分泌腺体的常染色体显性遗传病, 常同时或先后发生两种以上内分泌肿瘤。MEN相关肿瘤包括原发性甲状旁腺功能亢进症、嗜铬细胞瘤、甲状腺髓样癌、胰腺神经内分泌肿瘤和垂体瘤等, 这些肿瘤的临床特点和治疗方案与散发性肿瘤比较既有相似之处, 亦有其特殊性。近年来, MEN相关肿瘤的治疗已经达成了一些共识, 但仍存在较多争议, 手术时机及手术切除范围是争议的焦点。
    Abstract: Multiple endocrine neoplasia (MEN) is an autosomal dominant hereditary disease involving multiple endocrine glands with two or more endocrine tumors occurring simultaneously or successively. MEN-related tumors include primary hyperparathyroidism, pheochromocytoma, medullary thyroid cancer, pancreatic neuroendocrine neoplasia, and pituitary adenoma, etc. Although the clinical characteristics and treatment of these tumors are similar to those of sporadic tumors, there are differences in some aspects. In recent years, there has been some consensus achieved on the treatment of MEN-related tumors. But there are also some controversies. The timing and scope of surgical resection are the focus of controversies.
    利益冲突  无
    • HTML全文
    • 参考文献(20)
  • [1] Al-Salameh A, Baudry C, Cohen R. Update on multiple endocrine neoplasia Type 1 and 2[J]. Presse Med, 2018, 47:722-731. doi:  10.1016/j.lpm.2018.03.005
    [2] Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1(MEN1)[J]. J Clin Endocrinol Metab, 2012, 97:2990-3011. doi:  10.1210/jc.2012-1230
    [3] Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome[J]. N Engl J Med, 1999, 341:635-644. doi:  10.1056/NEJM199908263410902
    [4] 中华医学会骨质疏松和骨矿盐疾病分会, 中华医学会内分泌分会代谢性骨病学组.原发性甲状旁腺功能亢进症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志, 2014, 7:187-198. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhgzsshgkyjbzz201403003
    [5] Lairmore TC, Govednik CM, Quinn CE, et al. A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1[J]. Surgery, 2014, 156:1326-1335. doi:  10.1016/j.surg.2014.08.006
    [6] 中华医学会内分泌学分会肾上腺学组.嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识[J].中华内分泌代谢杂志, 2016, 32:181-187. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhnfmdx201603002
    [7] 邓建华, 李汉忠.嗜铬细胞瘤/副神经节瘤基因突变相关遗传综合征[J].协和医学杂志, 2015:161-165. http://www.cqvip.com/QK/70803X/201503/665023395.html
    [8] Castinetti F, Qi XP, Walz MK, et al. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2:an international retrospective population-based study[J]. Lancet Oncol, 2014, 15:648-655. doi:  10.1016/S1470-2045(14)70154-8
    [9] 樊华, 张玉石, 李汉忠, 等.保留肾上腺功能的腹腔镜双侧嗜铬细胞瘤切除术[J].中华内分泌外科杂志, 2017, 11:184-187. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=nfmwk201703003
    [10] Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25:567-610. doi:  10.1089/thy.2014.0335
    [11] Raue F, Frank-Raue K. Update on Multiple Endocrine Neoplasia Type 2:Focus on Medullary Thyroid Carcinoma[J]. J Endocr Soc, 2018, 2:933-943. doi:  10.1210/js.2018-00178
    [12] Krampitz GW, Norton JA. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma[J]. Cancer, 2014, 120:1920-1931. doi:  10.1002/cncr.28661
    [13] Marx SJ. Recent Topics Around Multiple Endocrine Neop-lasia Type 1[J]. J Clin Endocrinol Metab, 2018, 103:1296-1301. doi:  10.1210/jc.2017-02340
    [14] Falconi M, Eriksson B, Kaltsas G, et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Funct-ional Pancreatic Neuroendocrine Tumors[J]. Neuroendocrinology, 2016, 103:153-171. doi:  10.1159/000443171
    [15] Shah M, Goldner W, Benson A, et al. NCCN Clinical Practice Guidelines in Oncology:Neuroendocrine and Adrenal Tumors[J]. J Natl Compr Canc Netw, 2018, 16:693-702. doi:  10.6004/jnccn.2018.0056
    [16] Albers MB, Manoharan J, Bartsch DK. Contemporary surg-ical management of the Zollinger-Ellison syndrome in mul-tiple endocrine neoplasia type 1[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33:101318. doi:  10.1016/j.beem.2019.101318
    [17] Pavel M, Valle JW, Eriksson B, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms:Systemic Therapy-Biotherapy and Novel Targeted Agents[J]. Neuroendocrinology, 2017, 105:266-280. doi:  10.1159/000471880
    [18] Hicks R, Kwekkeboom D, Krenning E, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroen-docrine Neoplasia Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues[J]. Neuroendocrinology, 2017, 105:295-309. doi:  10.1159/000475526
    [19] Wu Y, Gao L, Guo X, et al. Pituitary adenomas in patients with multiple endocrine neoplasia type 1:a single-center experience in China[J]. Pituitary, 2019, 22:113-123. doi:  10.1007/s11102-019-00939-x
    [20] De Laat JM, Dekkers OM, Pieterman CR, et al. Long-Term Natural Course of Pituitary Tumors in Patients With MEN1:Results From the DutchMEN1 Study Group (DMSG)[J]. J Clin Endocrinol Metab, 2015, 100:3288-3296. doi:  10.1210/JC.2015-2015
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  346
  • HTML全文浏览量:  40
  • PDF下载量:  128
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-03-27
  • 刊出日期:  2020-07-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！